These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 12500103)

  • 1. Short of complete abstinence: an analysis exploration of multiple drinking episodes in alcoholism treatment trials.
    Wang SJ; Winchell CJ; McCormick CG; Nevius SE; O'Neill RT
    Alcohol Clin Exp Res; 2002 Dec; 26(12):1803-9. PubMed ID: 12500103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment.
    O'Malley SS; Garbutt JC; Gastfriend DR; Dong Q; Kranzler HR
    J Clin Psychopharmacol; 2007 Oct; 27(5):507-12. PubMed ID: 17873686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
    Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
    Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
    J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial.
    O'Malley SS; Sinha R; Grilo CM; Capone C; Farren CK; McKee SA; Rounsaville BJ; Wu R
    Alcohol Clin Exp Res; 2007 Apr; 31(4):625-34. PubMed ID: 17374042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in heavy drinking as a treatment outcome in alcohol dependence.
    Gastfriend DR; Garbutt JC; Pettinati HM; Forman RF
    J Subst Abuse Treat; 2007 Jul; 33(1):71-80. PubMed ID: 17588491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and methodological utility of a composite outcome measure for alcohol treatment research.
    Zweben A; Cisler RA
    Alcohol Clin Exp Res; 2003 Oct; 27(10):1680-5. PubMed ID: 14574241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
    Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
    Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dependent and problem drinking over 5 years: a latent class growth analysis.
    Delucchi KL; Matzger H; Weisner C
    Drug Alcohol Depend; 2004 Jun; 74(3):235-44. PubMed ID: 15194201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does participation in an alcohol administration study increase risk for excessive drinking?
    Pratt WM; Davidson D
    Alcohol; 2005 Nov; 37(3):135-41. PubMed ID: 16713501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rates and correlates of relapse among individuals in remission from DSM-IV alcohol dependence: a 3-year follow-up.
    Dawson DA; Goldstein RB; Grant BF
    Alcohol Clin Exp Res; 2007 Dec; 31(12):2036-45. PubMed ID: 18034696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome variables and their assessment in alcohol treatment studies: 1968-1998.
    Finney JW; Moyer A; Swearingen CE
    Alcohol Clin Exp Res; 2003 Oct; 27(10):1671-9. PubMed ID: 14574240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of extended-release naltrexone on holiday drinking in alcohol-dependent patients.
    Lapham S; Forman R; Alexander M; Illeperuma A; Bohn MJ
    J Subst Abuse Treat; 2009 Jan; 36(1):1-6. PubMed ID: 18775624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the use of naltrexone: an integration of preclinical and clinical findings.
    O'Malley SS; Froehlich JC
    Recent Dev Alcohol; 2003; 16():217-45. PubMed ID: 12638640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amisulpride does not prevent relapse in primary alcohol dependence: results of a pilot randomized, placebo-controlled trial.
    Marra D; Warot D; Berlin I; Hispard E; Notides C; Tilikete S; Payan C; Lépine JP; Dally S; Aubin HJ
    Alcohol Clin Exp Res; 2002 Oct; 26(10):1545-52. PubMed ID: 12394288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rational approach to the pharmacotherapy of alcohol dependence.
    Petrakis IL
    J Clin Psychopharmacol; 2006 Dec; 26 Suppl 1():S3-12. PubMed ID: 17114952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acculturation, drinking, and alcohol abuse and dependence among Hispanics in the Texas-Mexico border.
    Caetano R; Ramisetty-Mikler S; Wallisch LS; McGrath C; Spence RT
    Alcohol Clin Exp Res; 2008 Feb; 32(2):314-21. PubMed ID: 18162071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an alcohol deprivation and escalation effect in C57BL/6J mice.
    Melendez RI; Middaugh LD; Kalivas PW
    Alcohol Clin Exp Res; 2006 Dec; 30(12):2017-25. PubMed ID: 17117967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal patterns of binge drinking among first year college students with a history of tobacco use.
    Beets MW; Flay BR; Vuchinich S; Li KK; Acock A; Snyder FJ;
    Drug Alcohol Depend; 2009 Jul; 103(1-2):1-8. PubMed ID: 19423242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum sialic acid levels are increased during relapse to alcohol drinking: a pilot study.
    Pönniö M; Sillanaukee And P; Franck J
    Alcohol Clin Exp Res; 2002 Sep; 26(9):1365-7. PubMed ID: 12351931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.